Life Sciences Litigation & Enforcement Team

ID: 1b83a4c4-2619-30fb-68c4

/

Claimed Record

/

Organization: Ropes & Gray

Mid-Year NERA Report Shows COVID-19-Related Federal Securities Litigation Targeting Pharmaceutical Industry

Life Sciences Securities Litigation · July 17, 2020

S.D.N.Y. Preliminarily Approves $1.6 Million Settlement in Class Action Concerning Development of an OxyContin Alternative

Life Sciences Securities Litigation · July 17, 2020

First Circuit Affirms Dismissal of Action Regarding Statements Concerning Manufacturing of Eye Drug

Life Sciences Securities Litigation · April 9, 2020

Cornerstone Research Report Shows Continued Rate of Federal Securities Litigation Filings Targeting Pharmaceutical Industry

Life Sciences Securities Litigation · January 29, 2020

District Court Judge Partially Dismisses Claims Against Celgene, But Allows Allegations Regarding Misleading Statements About Sales Projections and FDA Approval to Proceed

Life Sciences Securities Litigation · December 19, 2019

Practice Areas

Class Action & Mass Torts

Jurisdictions